What are the recent trends in market size and growth for the autoimmune disease diagnosis market?
The autoimmune disease diagnosis market size has grown strongly in recent years. It will grow from $5.84 billion in 2024 to $6.25 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to the rising incidence of autoimmune diseases, emerging markets growth, increased healthcare expenditure, and high prevalence in women.
The autoimmune disease diagnosis market size is expected to see strong growth in the next few years. It will grow to $8.81 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increased funding for autoimmune (ai) diagnostics, faster economic growth, growing awareness about autoimmune diseases, and biomarker discovery. Major trends in the forecast period include partnering with other players, investing in artificial intelligence companies, collaborating with the government, and developing at-home rapid test kits.
Get Your Free Sample of The Global Autoimmune Disease Diagnosis Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3231&type=smp
How have varous drivers impacted the growth of the autoimmune disease diagnosis market?
A high incidence of autoimmune diseases contributed to the growth of the autoimmune disease diagnosis market. For instance, in February 2023, according to Multiple Sclerosis Australia, an Australia-based national non-profit organization dedicated to research and advocacy on behalf of those aggrieved by multiple sclerosis, there were 33,335 Multiple Sclerosis patients in Australia in 2021, a 30% (7,728) increase over the preceding four years (25,607). Therefore, the increasing incidence of autoimmune diseases across the globe is driving the growth of the autoimmune disease diagnosis market.
What are the primary segments of the autoimmune disease diagnosis market?
The autoimmune disease diagnosis market covered in this report is segmented –
1) By Product: Consumables And Assay Kits, Instruments
2) By End User: Clinical Laboratories, Hospitals, Others
3) By Test Type: Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests
Subsegments:
1) By Consumables And Assay Kits: ELISA Kits, Reagents And Test Kits, Sample Collection And Preservation Devices, Control And Calibration Materials
2) By Instruments: Immunoassay Analyzers, Flow Cytometers, Luminometers, Microscopes, Other Diagnostic Devices
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
Which firms are leading the autoimmune disease diagnosis market?
Major companies operating in the autoimmune disease diagnosis market include Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Danaher Corporation, AESKU Diagnostics GmbH & Co. KG, Trinity Biotech plc., bioMérieux SA, SQI Diagnostics, SCHILLER Healthcare India Pvt. Ltd, Covidien Healthcare India Private Limited, Philips Healthcare India, Fisher & Paykel Healthcare India Private Limited, Smith’s Medical India Pvt Ltd, Agappe Diagnostics Ltd, Accord Medical Products Private Limited, Lepu Medical Technology Company (Beijing) Co., Ltd, Yuwell – Jiangsu Yuyue Medical Equipment & Supply Co., Ltd, Shanghai Runda Medical Technology Co., Ltd, GE Healthcare China Co., Ltd, Roche Holding AG, Koninklijke Philips, Theradiag, Sanofi, Themis Bioscience, Becton Dickinson and Company
How will industry trends affect the trajectory of the autoimmune disease diagnosis market?
Biosensors and nano biosensors for rapid detection is a novel tool for the detection of antibodies in the autoimmune disease diagnosis market. They are highly preferred because of their low cost, high sensitivity, simple of use, multiplexing abilities, and rapid diagnosis. Besides measuring the number of antibodies in human blood serum with extremely high sensitivity, it also quantifies the activity of antibodies as the assay employs portable optical label-free biosensors based on spectral correlation interferometry. This point-of-care technology gives a more integrated, informative, timely, and precise diagnosis of autoimmune diseases when compared to conventional ones.
Which geographic trends are shaping the autoimmune disease diagnosis market, and which region has the highest market share?
The countries covered in the autoimmune disease diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
What Does The Autoimmune Disease Diagnosis Market Report 2025 Offer?
The autoimmune disease diagnosis market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Autoimmune disease diagnosis refers to the diagnosis of diseases in which the production of antibodies takes place in the body which attacks and destroys healthy cells in the body. These include Crohn’s disease, rheumatoid arthritis, Hashimoto’s disease, multiple sclerosis, Grave’s disease, psoriasis, coeliac disease, type 1 diabetes, lupus, and inflammatory bowel syndrome, and are diagnosed by immunological tests.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3231
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
